PHARMACYTE BIOTECH, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -4.7% | -4.7% | -4.7% |
| FY2023 | -5.9% | -5.9% | -5.9% |
| FY2024 | 1.2% | 1.2% | 0.6% |
| FY2025 | 59.1% | 59.1% | 55.6% |
| FY2026 | -58.3% | -58.3% | -41.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -4.7% | -4.7% | -4.7% |
| FY2023 | -5.9% | -5.9% | -5.9% |
| FY2024 | 1.2% | 1.2% | 0.6% |
| FY2025 | 59.1% | 59.1% | 55.6% |
| FY2026 | -58.3% | -58.3% | -41.5% |